Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/36040
PERINATAL ANALYSES OF ZIKA- AND DENGUE VIRUS-SPECIFIC NEUTRALIZING ANTIBODIES: A MICROCEPHALY CASE-CONTROL STUDY IN AN AREA OF HIGH DENGUE ENDEMICITY IN BRAZIL
Adulto
Anticorpos Neutralizantes / sangue
Anticorpos Antivirais / sangue
Brasil / epidemiologia
Estudos de Casos e Controles
Dengue / diagnóstico
Dengue / epidemiologia
Vírus da Dengue / imunologia
Feminino
Humanos
Imunoglobulina G / sangue
Imunoglobulina M / sangue
Recém-Nascido
Masculino
Microcefalia / epidemiologia
Microcefalia / etiologia
Gravidez
Complicações Infecciosas na Gravidez / diagnóstico
Complicações Infecciosas na Gravidez / epidemiologia
Adulto Jovem
Zika virus / imunologia
Infecção por Zika virus / complicações
Infecção por Zika virus / diagnóstico
Infecção por Zika virus / epidemiologia
Author
Affilliation
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Recife, PE, Brasil / Universidade de Pernambuco. Faculdade de Ciências Médicas. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Recife, PE, Brasil / Universidade Federal de Pernambuco. Recife, PE, Brasil.
Universidade de Pernambuco. Faculdade de Ciências Médicas. Recife, PE, Brasil / Universidade Federal de Pernambuco. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Recife, PE, Brasil.
Universidade de Pernambuco. Faculdade de Ciências Médicas. Recife, PE, Brasil.
Universidade de Pernambuco. Faculdade de Ciências Médicas. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Recife, PE, Brasil / University of Pittsburgh. Department of Infectious Diseases and Microbiology. Pittsburgh, Pennsylvania, United States of America.
London School of Hygiene & Tropical Medicine. Department of Infectious Disease Epidemiology. London, United Kingdom.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Recife, PE, Brasil / Universidade Federal de Pernambuco. Recife, PE, Brasil.
Universidade de Pernambuco. Faculdade de Ciências Médicas. Recife, PE, Brasil / Universidade Federal de Pernambuco. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Recife, PE, Brasil.
Universidade de Pernambuco. Faculdade de Ciências Médicas. Recife, PE, Brasil.
Universidade de Pernambuco. Faculdade de Ciências Médicas. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Recife, PE, Brasil / University of Pittsburgh. Department of Infectious Diseases and Microbiology. Pittsburgh, Pennsylvania, United States of America.
London School of Hygiene & Tropical Medicine. Department of Infectious Disease Epidemiology. London, United Kingdom.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Recife, PE, Brasil.
Abstract
Laboratory confirmation of Zika virus (ZIKV) infection during pregnancy is challenging due to cross-reactivity with dengue virus (DENV) and limited knowledge about the kinetics of anti-Zika antibody responses during pregnancy. We described ZIKV and DENV serological markers and the maternal-fetal transfer of antibodies among mothers and neonates after the ZIKV microcephaly outbreak in Northeast Brazil (2016). We included 89 microcephaly cases and 173 neonate controls at time of birth and their mothers. Microcephaly cases were defined as newborns with a particular head circumference (2 SD below the mean). Two controls without microcephaly were matched by the expected date of delivery and area of residence. We tested maternal serum for recent (ZIKV genome, IgM and IgG3 anti-NS1) and previous (ZIKV and DENV neutralizing antibodies [NAbs]) markers of infection. Multiple markers of recent or previous ZIKV and DENV infection in mothers were analyzed using principal component analysis (PCA). At delivery, 5.6% of microcephaly case mothers and 1.7% of control mothers were positive for ZIKV IgM. Positivity for ZIKV IgG3 anti-NS1 was 8.0% for case mothers and 3.5% for control mothers. ZIKV NAbs was slightly higher among mothers of cases (69.6%) than that of mothers of controls (57.2%; p = 0.054). DENV exposure was detected in 85.8% of all mothers. PCA discriminated two distinct components related to recent or previous ZIKV infection and DENV exposure. ZIKV NAbs were higher in newborns than in their corresponding mothers (p<0.001). We detected a high frequency of ZIKV exposure among mothers after the first wave of the ZIKV outbreak in Northeast Brazil. However, we found low sensitivity of the serological markers to recent infection (IgM and IgG3 anti-NS1) in perinatal samples of mothers of microcephaly cases. Since the neutralization test cannot precisely determine the time of infection, testing for ZIKV immune status should be performed as early as possible and throughout pregnancy to monitor acute Zika infection in endemic areas.
DeCS
AdolescenteAdulto
Anticorpos Neutralizantes / sangue
Anticorpos Antivirais / sangue
Brasil / epidemiologia
Estudos de Casos e Controles
Dengue / diagnóstico
Dengue / epidemiologia
Vírus da Dengue / imunologia
Feminino
Humanos
Imunoglobulina G / sangue
Imunoglobulina M / sangue
Recém-Nascido
Masculino
Microcefalia / epidemiologia
Microcefalia / etiologia
Gravidez
Complicações Infecciosas na Gravidez / diagnóstico
Complicações Infecciosas na Gravidez / epidemiologia
Adulto Jovem
Zika virus / imunologia
Infecção por Zika virus / complicações
Infecção por Zika virus / diagnóstico
Infecção por Zika virus / epidemiologia
Share